Revolution to a New Standard Treatment of Diabetic Macular Edema

• Autores: Lee M. Jampol, Neil M. Bressler, Adam R. Glassman
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 311, Nº. 22, 2014, págs. 2269-2270
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • The prevalence of diabetes mellitus worldwide is increasing, in part due to an obesity epidemic. Thus, prevention and treatment of vision loss from diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema (DME), has become more important.1 Diabetic macular edema, a swelling of the central part of the macula (Figure), affects approximately 746 000 adults aged 40 years or older in the United States (approximately 4% with diabetes develop DME).2